Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Mark J. Rubash Sells 1,709 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Mark J. Rubash sold 1,709 shares of the business’s stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $380.00, for a total transaction of $649,420.00. Following the completion of the sale, the director now directly owns 16,051 shares of the company’s stock, valued at approximately $6,099,380. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $383.05 on Tuesday. The stock has a market capitalization of $135.87 billion, a price-to-earnings ratio of 69.14, a PEG ratio of 4.93 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The stock has a fifty day moving average of $385.29 and a 200-day moving average of $351.11.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the firm posted $1.00 earnings per share. The business’s revenue for the quarter was up 11.5% on a year-over-year basis. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently added to or reduced their stakes in ISRG. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 0.7% in the third quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock worth $8,730,184,000 after purchasing an additional 196,316 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Intuitive Surgical by 1.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock valued at $5,726,102,000 after buying an additional 272,741 shares during the last quarter. Edgewood Management LLC increased its stake in shares of Intuitive Surgical by 7.9% in the fourth quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock valued at $1,731,016,000 after buying an additional 374,667 shares during the period. Jennison Associates LLC raised its position in shares of Intuitive Surgical by 6.4% during the third quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock worth $1,340,205,000 after acquiring an additional 274,692 shares during the last quarter. Finally, Fisher Asset Management LLC lifted its stake in shares of Intuitive Surgical by 2.0% in the fourth quarter. Fisher Asset Management LLC now owns 4,494,373 shares of the medical equipment provider’s stock worth $1,516,222,000 after acquiring an additional 88,977 shares during the period. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ISRG. Mizuho increased their target price on shares of Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Thursday, January 25th. Citigroup increased their price target on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Truist Financial lifted their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Piper Sandler upped their target price on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday, April 19th. Finally, Jefferies Financial Group raised their price target on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.